Track the 美好医疗 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 美好医疗 has recorded 2 reports. Market capitalisation: €12.7bn. The latest transaction was filed on 11 February 2026 (Sale). Among the most active insiders: JOEL CHAN. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
美好医疗是一家专注于医疗保健和制药领域的公司,提供各种医疗服务和产品。该公司在XSHE市场上市。